Invitae Corporation
NVTA
Peringkat dalam Saham
#35785
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Harga Saham
$0.016
Terakhir disinkronkan: 2024-03-11
Kapitalisasi Pasar
$3.27M
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
5,233.33%
Negara
US
Perdagangan Invitae Corporation (NVTA)
Kategori
Healthcare
Laba untuk Invitae Corporation (NVTA)
Laba pada Sep 2023 TTM: $-1.45B
Menurut laporan keuangan terbaru dari Invitae Corporation, laba saat ini perusahaan adalah $-1.45B. Pada tahun 2022, perusahaan memperoleh laba sebesar $-3.15B, penurunan dibandingkan dengan laba tahun 2021 sebesar $-415.86M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Invitae Corporation dari 2016 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $-1.45B | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $-3.15B | 657.75% |
| 2021 | $-415.86M | -41.78% |
| 2020 | $-714.27M | 174.28% |
| 2019 | $-260.42M | 97.05% |
| 2018 | $-132.16M | 5.52% |
| 2017 | $-125.24M | 24.92% |
| 2016 | $-100.26M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | -623.31% |
US
|
|
| $4.76B | -427.50% |
US
|
|
| $-252.70M | -82.62% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -214.03% |
US
|
